High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Johnson, Andrew M F ^a   Costanzo, Anne ^d   Gareau, Melanie G ^c   Armando, Aaron M ^b   Quehenberger, Oswald ^a,b   Jameson, Julie M ^d   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b San Diego   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FAT CONTENT; FECES; GENE EXPRESSION; IMMUNE SYSTEM; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; LIVER; MACROPHAGE; METABOLIC DISORDER; MONOCYTE; MOUSE; NONHUMAN; OBESITY; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; INFLAMMATION; INTESTINE; LEUKOCYTE COUNT; METABOLISM; PATHOLOGY; PERMEABILITY;

MUS;

ANIMALS; DIET, HIGH-FAT; EOSINOPHILS; INFLAMMATION; INTESTINES; LEUKOCYTE COUNT; MICE; MICE, INBRED C57BL; OBESITY; PERMEABILITY;

EID: 84926678423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122195     Document Type: Article

References (42)

1. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011; 3: 559-572. doi: 10.1002/emmm.201100159 PMID: 21735552
2. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56: 1761-1772. PMID: 17456850
3. Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia. 2011; 54: 3055-3061. doi: 10. 1007/s00125-011-2329-8 PMID: 21976140
4. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57: 1470-1481. doi: 10.2337/db07-1403 PMID: 18305141
5. Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012; 142: 1100-1101 e1102. doi: 10.1053/j.gastro.2012.01.034 PMID: 22326433
6. Teixeira TF, Souza NC, Chiarello PG, Franceschini SC, Bressan J, Ferreira CL, et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr. 2012; 31: 735-740. doi: 10.1016/j.clnu.2012.02.009 PMID: 22444236
7. Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond). 2010; 7: 19. doi: 10.1186/1743-7075-7-19 PMID: 20222989
8. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007; 292: G518-525. PMID: 17023554
9. Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res. 2012; 32: 637-647. doi: 10. 1016/j.nutres.2012.07.003 PMID: 23084636
10. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012; 336: 1268-1273. doi: 10.1126/science.1223490 PMID: 22674334
11. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010; 299: G440-448. doi: 10.1152/ajpgi.00098.2010 PMID: 20508158
12. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010; 5: e12191. doi: 10.1371/journal.pone.0012191 PMID: 20808947
13. Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, et al. Diet-induced obesity elevates colonic TNF-alpha in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem. 2012; 23: 1207-1213. doi: 10.1016/j.jnutbio.2011.07.002 PMID: 22209007
14. Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, et al. The combination of highfat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis. 2011; 10: 204. doi: 10.1186/1476-511X-10-204 PMID: 22073943
15. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012; 7: e34233. doi: 10.1371/journal.pone.0034233 PMID: 22457829
16. Li H, Lelliott C, Hakansson P, Ploj K, Tuneld A, Verolin-Johansson M, et al. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Metabolism. 2008; 57: 1704-1710. doi: 10.1016/j.metabol. 2008.07.029 PMID: 19013294
17. Medina-Contreras O, Geem D, Laur O, Williams IR, Lira SA, Nusrat A, et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest. 2011; 121: 4787-4795. doi: 10.1172/JCI59150 PMID: 22045567
18. Farache J, Zigmond E, Shakhar G, Jung S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol. 2013; 91: 232-239. doi: 10.1038/icb.2012. 79 PMID: 23399695
19. Hogan SP, Mishra A, Brandt EB, Royalty MP, Pope SM, Zimmermann N, et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol. 2001; 2: 353-360. PMID: 11276207
20. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008; 38: 709- 750. doi: 10.1111/j.1365-2222. 2008.02958.x PMID: 18384431
21. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov. 2013; 12: 117-129. doi: 10.1038/nrd3838 PMID: 23334207
22. Chu VT, Beller A, Rausch S, Strandmark J, Zanker M, Arbach O, et al. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. Immunity. 2014; 40: 582-593. doi: 10.1016/j.immuni.2014.02.014 PMID: 24745334
23. Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy. 2010; 40: 563-575. doi: 10.1111/j.1365-2222.2010.03484.x PMID: 20447076
24. Svensson-Frej M. Immunobiology of Intestinal Eosinophils -A Dogma in the Changing? Journal of Innate Immunity. 2011; 3: 565-576. doi: 10.1159/000328799 PMID: 21860213
25. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000; 20: 4106-4114. PMID: 10805752
26. Gareau MG, Jury J, MacQueen G, Sherman PM, Perdue MH. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut. 2007; 56: 1522-1528. PMID: 17339238
27. Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol. 2012; 18: 923-929. doi: 10.3748/wjg.v18.i9.923 PMID: 22408351
28. Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes. 2010; 59: 916-925. doi: 10.2337/db09-1403 PMID: 20103702
29. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112: 1821-1830. PMID: 14679177
30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796-1808. PMID: 14679176
31. Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 2009; 31: 502-512. doi: 10.1016/j. immuni.2009.06.025 PMID: 19733097
32. Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009; 31: 513-525. doi: 10.1016/j.immuni.2009.08.010 PMID: 19733489
33. Wen T, Besse JA, Mingler MK, Fulkerson PC, Rothenberg ME. Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proc Natl Acad Sci U S A. 2013; 110: 6067-6072. doi: 10.1073/pnas.1220572110 PMID: 23536294
34. Clarke LL. A guide to Ussing chamber studies of mouse intestine. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1151-1166. doi: 10.1152/ajpgi.90649.2008 PMID: 19342508
35. Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell. 2013; 152: 673-684. doi: 10.1016/j.cell.2013.01.041 PMID: 23415219
36. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-484. doi: 10.1038/nature07540 PMID: 19043404
37. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023. PMID: 17183309
38. Brignardello J, Morales P, Diaz E, Romero J, Brunser O, Gotteland M. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment Pharmacol Ther. 2010; 32: 1307-1314. doi: 10.1111/j.1365-2036.2010.04475.x PMID: 21050232
39. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011; 332: 243-247. doi: 10.1126/science.1201475 PMID: 21436399
40. Carlens J, Wahl B, Ballmaier M, Bulfone-Paus S, Forster R, Pabst O. Common gamma-chaindependent signals confer selective survival of eosinophils in the murine small intestine. J Immunol. 2009; 183: 5600-5607. doi: 10.4049/jimmunol.0801581 PMID: 19843944
41. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482: 179-185. doi: 10.1038/nature10809 PMID: 22297845
42. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010; 328: 228-231. doi: 10.1126/science.1179721 PMID: 20203013